Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
Rhea-AI Summary
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) has announced that it will release its third quarter 2024 financial results after market close on Wednesday, October 30, 2024. The company will host a conference call and live webcast at 5:00 p.m. U.S. EST to discuss the results and provide a business update.
All materials related to the financial results will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call. Interested parties can access the webcast through the company's website. A replay of the conference call will also be available on the investor relations website for those unable to attend the live event.
To participate in the live Q&A session, individuals must register using a provided link to receive confirmation and further details via email.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, BHC gained 2.14%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
LAVAL, QC / ACCESSWIRE / October 9, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2024 financial results after market close on Wednesday, October 30, 2024. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: | Wednesday, October 30, 2024 |
Time: | 5:00 p.m. U.S. EST |
Webcast: |
A replay of the conference call will be available on the investor relations website.
To participate in the live Q&A session, please register using this link to receive an email confirming your registration with further details.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
###
Investor Contact: |
| Media Contact: |
SOURCE: Bausch Health Companies Inc.
View the original press release on accesswire.com
FAQ
When will Bausch Health (BHC) release its Q3 2024 financial results?
What time is Bausch Health's (BHC) Q3 2024 earnings call scheduled for?
Where can I access Bausch Health's (BHC) Q3 2024 earnings materials?
How can I participate in Bausch Health's (BHC) Q3 2024 earnings call Q&A session?
